Detailed answers about PHARMAPREMIUM SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was PHARMAPREMIUM SERVICES LIMITED founded?
PHARMAPREMIUM SERVICES LIMITED was officially incorporated on 25 April 2007 and is registered under company number 06226754. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PHARMAPREMIUM SERVICES LIMITED?
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of PHARMAPREMIUM SERVICES LIMITED?
PHARMAPREMIUM SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PHARMAPREMIUM SERVICES LIMITED do?
PHARMAPREMIUM SERVICES LIMITED operates in the following sector: 64999 - Financial intermediation not elsewhere classified. This provides insight into the company's primary business activity and industry focus.
What is PHARMAPREMIUM SERVICES LIMITED's registered address?
The registered office address of PHARMAPREMIUM SERVICES LIMITED is C/O TOPPING PARTNERSHIP, INCOME HOUSE WATERSIDE, TRAFFORD PARK, MANCHESTER, ENGLAND, M17 1WD. This is the official address filed with Companies House for legal and statutory correspondence.
Is PHARMAPREMIUM SERVICES LIMITED financially stable?
The most recent accounts for PHARMAPREMIUM SERVICES LIMITED were made up to 31 March 2025, filed as DORMANT. Next accounts are due by 29 December 2026.
Has PHARMAPREMIUM SERVICES LIMITED changed its name?
Yes, PHARMAPREMIUM SERVICES LIMITED has had 1 previous name: HOME SAVE FOUNDATION LIMITED (changed 15 September 2025).